Raymond James Maintains Outperform on Tremor Intl, Raises Price Target to $31
Raymond James analyst Andrew Marok maintains Tremor Intl (NASDAQ:TRMR) with a Outperform and raises the price target from $27 to $31.
38 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares jumped 141% to $1.7950 after dropping 12% on Wednesday. Sonnet BioTherapeutics recently reported its financial results for the three months ended June 30th , 2021 and issued a business update.
Tremor Intl Q2 EPS $0.23 Up From $(0.02) YoY, Sales $81.38M Up From $35.70M YoY
Tremor Intl (NASDAQ:TRMR) reported quarterly earnings of $0.23 per share. This is a 1250 percent increase over losses of $(0.02) per share from the same period last year. The company reported $81.38 million in sales
Tremor Stock Gains On Solid Q2 Revenue Growth
Video and Connected TV (CTV) advertising company Tremor International Ltd (NASDAQ:TRMR) reported second-quarter FY21 revenue growth of 128% year-on-year to $81.4 million…
Earnings Scheduled For August 19, 2021
Companies Reporting Before The Bell
• Bilibili (NASDAQ:BILI) is likely to report quarterly loss at $2.86 per share on revenue of $658.78 million.
